We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$28.2B
AUM Growth
+$3.7B
Cap. Flow
+$629M
Cap. Flow %
2.23%
Top 10 Hldgs %
27.98%
Holding
1,934
New
25
Increased
581
Reduced
466
Closed
75

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$117M
2
MSFT icon
Microsoft
MSFT
+$84.2M
3
AVGO icon
Broadcom
AVGO
+$71.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$71.8M
5
CTSH icon
Cognizant
CTSH
+$60.7M

Top Sells

Rank Stock Value
1
MRSH
Marsh
MRSH
+$65.7M
2
AFL icon
Aflac
AFL
+$54.1M
3
HUM icon
Humana
HUM
+$54M
4
ZTS icon
Zoetis
ZTS
+$48.3M
5
PNC icon
PNC Financial Services
PNC
+$44.4M

Sector Composition

Rank Sector Weight
1 Technology 34.43%
2 Healthcare 16.09%
3 Financials 12.41%
4 Consumer Discretionary 10.83%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANF icon
1001
Abercrombie & Fitch
ANF
$4.42B
$102K ﹤0.01%
1,154
-375
-25% -$26.7K
GPI icon
1002
Group 1 Automotive
GPI
$3.42B
$102K ﹤0.01%
335
IBP icon
1003
Installed Building Products
IBP
$6.01B
$102K ﹤0.01%
558
-48
-8% -$6.74K
PECO icon
1004
Phillips Edison & Co
PECO
$5.46B
$102K ﹤0.01%
2,783
CADE
1005
DELISTED
Cadence Bank
CADE
$101K ﹤0.01%
3,425
+886
+35% +$21.6K
CPRI icon
1006
Capri Holdings
CPRI
$1.83B
$101K ﹤0.01%
2,005
CRSP icon
1007
CRISPR Therapeutics
CRSP
$4.73B
$101K ﹤0.01%
1,607
MMSI icon
1008
Merit Medical Systems
MMSI
$5.08B
$101K ﹤0.01%
1,325
PR
1009
Permian Resources
PR
$17.8B
$101K ﹤0.01%
7,395
+1,632
+28% +$22.3K
DTM icon
1010
DT Midstream
DTM
$14.1B
$100K ﹤0.01%
1,829
+381
+26% +$21K
ABCB icon
1011
Ameris Bancorp
ABCB
$5.85B
$99K ﹤0.01%
1,862
MOG.A icon
1012
Moog Inc Class A
MOG.A
$12.4B
$99K ﹤0.01%
683
-52
-7% -$6.73K
SFBS
1013
ServisFirst Bancshares
SFBS
$4.89B
$99K ﹤0.01%
1,488
THO icon
1014
Thor Industries
THO
$3.9B
$99K ﹤0.01%
840
ACA icon
1015
Arcosa
ACA
$7.13B
$98K ﹤0.01%
1,182
INSM icon
1016
Insmed
INSM
$21.4B
$98K ﹤0.01%
3,175
LNC icon
1017
Lincoln National
LNC
$8.73B
$98K ﹤0.01%
3,625
SNX icon
1018
TD Synnex
SNX
$20.4B
$98K ﹤0.01%
912
+219
+32% +$21.5K
AEIS icon
1019
Advanced Energy
AEIS
$11.6B
$97K ﹤0.01%
891
APLS
1020
DELISTED
Apellis Pharmaceuticals
APLS
$97K ﹤0.01%
1,622
CCU icon
1021
Compañía de Cervecerías Unidas
CCU
$2.12B
$97K ﹤0.01%
7,701
+5,170
+204% +$62.5K
PCVX icon
1022
Vaxcyte
PCVX
$7.81B
$97K ﹤0.01%
1,538
EXPO icon
1023
Exponent
EXPO
$3.24B
$96K ﹤0.01%
1,092
IRDM icon
1024
Iridium Communications
IRDM
$5.02B
$96K ﹤0.01%
2,331
SFM icon
1025
Sprouts Farmers Market
SFM
$8.13B
$96K ﹤0.01%
2,004
+534
+36% +$23.4K

Similar funds

KBC Group's Q4 2023 Portfolio in Review

As of Q4 2023, KBC Group held 1,934 positions worth $28.2B, up 15% from $24.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

KBC Group's Q4 2023 filing shows 25 new, 581 increased, 466 reduced and 75 closed positions. Its largest new stake was Veralto: 386,622 shares worth $31.8M. The largest sale was Marsh, an estimated $65.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q4 2023 buy was Veralto: 386,622 shares worth $31.8M.
  • KBC Group added most to NVIDIA in Q4 2023, an estimated $117M increase.
  • KBC Group's biggest Q4 2023 reduction was Marsh, cutting an estimated $65.7M.
  • KBC Group fully exited VMware, Inc in Q4 2023, selling an estimated $28.8M.
  • KBC Group's ten largest holdings make up 28% of its $28.2B portfolio in Q4 2023.
  • KBC Group opened 25 new positions and closed 75 in Q4 2023.
  • KBC Group's portfolio value rose 15% quarter-over-quarter to $28.2B.

Based on KBC Group's 13F filing for Q4 2023, filed 13 Feb 2024.